Debbie Lin, PhD

Dr. Debbie Lin is Executive Director at Boehringer Ingelheim Venture Fund in the US. She started the Fund’s North American investment efforts in Digital Healthcare.  Joining BI in 2008, she has worked across various regions and divisions in the US and globally ranging from Health economics and outcomes to Corporate Strategy and Development. Her Doctorate is in Pharmacogenomics and Bioinformatics from UCSF, she has a Masters in Engineering from Stanford University and a Masters in Health Policy from UCLA